Trials / Completed
CompletedNCT00043836
The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure
A Pilot Study Of ALT-711 In Elderly Patients With Isolated Diastolic Heart Failure: The DIAMOND Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Synvista Therapeutics, Inc · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the hypothesis that treatment with oral ALT-711 twice daily for 16 weeks will improve aortic distensibility, exercise tolerance, and quality of life in elderly patients with isolated diastolic heart failure (DHF), and that the improvements in exercise tolerance will correlate with the improvements in aortic distensibility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALT-711 |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2003-02-01
- Completion
- 2005-10-01
- First posted
- 2002-08-15
- Last updated
- 2009-09-02
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00043836. Inclusion in this directory is not an endorsement.